Pharmacokinetics of metformin after intravenous and oral administration to man

Edit. Biguanides and lactic acidosis in diabetics. Br. Med. J.1977/II, 1436

Isnard, F., Lavieuville, M.: Acidose lactique et biguanides: Etat actuelle de la question en France. J. Diabetol. Hôtel-Dieu18, 362?375 (1977)

Phillips, P.J., Thomas, D.W., Harding, P.E.: Biguanides and lactic acidosis. Br. Med. J.1977/I, 234

Bergman, U., Boman, G., Wiholm, B.-E.: Epidemiology of adverse drug reactions to phenformin and metformin. Br. Med. J.1978/II, 464?466

Gustafson, A., Björntorp, P., Fahlén, M.: Metformin administration in hyperlipidemic states. Acta Med. Scand.190, 491?494 (1971)

Sirtori, C.R., Tremoli, E., Sirtori, M., Conti, F., Paoletti, R.: Treatment of hypertriglyceridemia with metformin. Effectiveness and analysis of results. Atherosclerosis26, 583?592 (1977)

Marquié, G., Agid, R.: Effects inhibiteurs d'un biguanide antidiabétique, le NN-diméthylbiguanide, sur les perturbations lipidiques entrainées par l'administration de cholestérol chez le lapin. C. R. Acad. Sci. [D] (Paris)266, 2465?2468 (1968)

Agid, R., Marquié, G.: The effects of metformin on lipid-induced atherosclerosis. Adv. Metab. Disord.2, Suppl. 2, 575?586 (1973)

Marquié, G.: Effect of metformin on lipid metabolism in the rabbit aortic wall. Atherosclerosis30, 165?175 (1978)

Sirtori, C.R., Catapano, A., Ghiselli, G.C., Shore, B., Shore, V.: Effect of metformin on lipoprotein composition in rabbits and man. Prot. Biol. Fluids25, 379?383 (1978)

Beckmann, R.: Resorption, Verteilung im Organismus und Ausscheidung von Metformin. Diabetologia3, 318?324 (1969)

Lennard, M.S., Casey, C., Tucker, G.T., Woods, H.F.: Determination of metformin in biological samples. Br. J. Clin. Pharmacol.6, 183?185 (1978)

Assan, R., Heuclin, Ch., Caneval, D., Bismuth, Ch., George, J., Girard, J.R.: Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia13, 211?217 (1977)

Bircher, J., Küpfer, A., Gikalov, I., Preisig, R.: Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin. Pharmacol. Ther.20, 484?492 (1976)

Ehrnebo, M., Agurell, S., Jalling, B., Boréus, L.O.: Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults. Eur. J. Clin. Pharmacol.3, 189?193 (1971)

Walker, S.R.: The influence of protein binding on the excretion of some sulphanilamidopyrimidines in man. J. Pharm. Pharmacol.22, 574?577 (1970)

Loo, T.L., Tanner, B.B., Housholder, G.E., Shepard, B.J.: Some pharmacokinetic aspects of 5-(dimethyltriazeno)-imidazole-4-carboxamide in the dog. J. Pharm. Sci.57, 2126?2131 (1968)

Metzler, C.M.: The Upjohn Company, Kalamazoo, Michigan 49001

Loo, J.C.K., Riegelman, S.: Assessment of Pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion. J. Pharm. Sci.59, 53?55 (1970)

Gibaldi, M., Perrier, D.: Pharmacokinetics. Drugs and the pharmaceutical sciences, Vol. 1. New York: Marcel Dekker 1975

Garrett, E.R., Tsau, J., Hinderling, P.H.: Application of ion-pair methods to drug extraction from biological fluids II: Quantitative determination of biguanides in biological fluids and comparison of protein binding estimates. J. Pharm. Sci.61, 1411?1418 (1972)

Beckmann, R.: The fate of biguanides in man. Ann. NY Acad. Sci.148, 820?832 (1968)

Mehnert, H.: Pharmacokinetics of blood glucose lowering biguanide derivatives. Acta Diabetol. Lat.6, Suppl. 1, 137?142 (1969)

Karam, J., Martin, S., Levin, S., Forsham, P.H.: Circulating phenformin (Pf) levels: implications as to Pf's therapeutic action. Diabetes23, Suppl. 1, 375 (1974) (Abstr.)

Alkalay, D., Khemani, L., Wagner, W.E., Bartlett, F.: Pharmacokinetics of phenformin in man. J. Clin. Pharmacol.15, 446?448 (1975).

Matin, S.B., Karam, J.H., Forsham, P.H.: Simple electron capture gas chromatographic method for the determination of oral hypoglycemic biguanides in biological fluids. Anal. Chem.47, 545?548 (1975).

Beckmann, R.: Über die Resorption und den biologischen Abbau von 1-(?-Phenäthyl)-biguanid (Phenformin). Diabetologia3, 368 (1967)

Rây, P.: Complex compounds of biguanides and guanylureas with metallic elements. Chem. Rev.61, 313?369 (1961)

Mucklow, J.C., Bending, M.R., Kahn, G.C., Dollery, C.T.: Drug concentration in saliva. Clin. Pharmacol. Ther.24, 563?570 (1978)

Cohen, Y., Costerousse, O.: Etude autoradiographique chez la Souris d'un antidiabétigue oral, le NN Dimethyl-biguanide marqué au carbone 14. Thérapie16, 109?120 (1961)